This research study is assessing an investigational drug combination that contains two common, FDA-approved asthma drugs: one for rapid relief from flares, and one that targets the long-term lung inflammation that causes symptoms. Each asthma drug was approved by FDA for use separately for their respective asthma indications and not for use in combination.
This research study is assessing an investigational drug combination that contains two common, FDA-approved asthma drugs: one for rapid relief from flares, and one that targets the long-term lung inflammation that causes symptoms. Each asthma drug was approved by FDA for use separately for their respective asthma indications and not for use in combination.
• Be 12 years of age or older
• Have an asthma diagnosis
• No-cost study-required care
• No-cost study drug
• Compensation for time and travel
Asthma can be genetic.
Symptoms may include wheezing, excess mucus, coughing, chest pain/tightness or feeling short of breath. In addition, when not properly treated, asthma can damage the lungs.
Rescue inhalers work rapidly to control
asthma attacks and help you breathe,
but they don’t address the underlying
problem of airway and lung inflammation.
An investigational drug combination
may help calm flares on the spot and
prevent exacerbationsin the long term.
Asthma can be genetic. Symptoms may include wheezing, excess mucus, coughing, chest pain/tightness or feeling short of breath. In addition, when not properly treated, asthma
can damage the lungs.
Rescue inhalers work rapidly to control asthma attacks and help you breathe, but they don’t address the underlying problem of airway and lung inflammation.
An investigational drug combination may help calm flares on the spot and prevent exacerbations in the long term
Answer some questions about your/your teen’s health
Tell us a little bit
about you/your teen
Connect to a study
site in your area
Just takes a few minutes